
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL
Overview | Financials
Company Name | Adlai Nortye Ltd. American Depositary Shares |
Symbol | ANL |
Currency | USD |
Price | 1.45 |
Market Cap | 15,097,835 |
Dividend Yield | 0% |
52-week-range | 1.1 - 3.89 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Yang Lu |
Website | https://www.adlainortye.com |
An error occurred while fetching data.
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD